Abstract
Oral β-alanine (βA) doses larger than 800 mg commonly result in unpleasant sensory symptoms (paresthesia). However, the association of form (pure vs. slow-release) with side-effects has not been fully described. The aim of this single-blinded, randomized three-arm clinical trial was to compare plasma kinetics and symptoms following βA bolus administration in solution or in slow-release tablet form. Eleven healthy adults ingested 1.6 g of a pure βA reference solution (REF), 1.6 g in slow-release βA tablets (TAB) or a placebo (PLA) after an overnight fast. During the next 6 h, urinary and plasma βA concentrations were measured and questionnaires about intensity, nature (pins and needles, itching, flushing, irritation, numbness, soreness), and spatial distribution of unusual sensations were filled in. TAB resulted in a smaller peak plasma concentration than REF (82 vs. 248 μmol L−1, p < 0.001), delayed time to peak (1.0 vs. 0.5 h, p < 0.01) no difference in area under the curve, reduced loss in urine (202 vs. 663 μmol, p < 0.0001), and improved retention (98.9 vs. 96.3%, p < 0.001). Symptoms described as “pins and needles” were perceived rapidly on the skin of the arms and trunk after REF (T max = 15 min) and their time course nearly mimicked plasma concentrations. Maximum intensity scores were weaker with TAB (“very low”) than with REF (“low”, p < 0.001), while TAB and PLA did not differ with respect to side-effects. In summary, ingesting 1.6 g βA in slow-release tablets rather than pure in solution results in slower absorption kinetics, improved whole body retention and sensory side-effects that cannot be differentiated from PLA.
Similar content being viewed by others
References
Abe H (2000) Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochem (Mosc) 65:757–765
Artioli GG, Gualano B, Smith A, Stout J, Lancha AH Jr (2010) Role of beta-alanine supplementation on muscle carnosine and exercise performance. Med Sci Sports Exerc. 42:1162–1173
Baguet A, Reyngoudt H, Pottier A, Everaert I, Callens S, Achten E, Derave W (2009) Carnosine loading and washout in human skeletal muscles. J Appl Physiol 106:837–842
Baguet A, Bourgois J, Vanhee L, Achten E, Derave W (2010) Important role of muscle carnosine in rowing performance. J Appl Physiol 109:1096–1101
Bakardjiev A, Bauer K (1994) Transport of beta-alanine and biosynthesis of carnosine by skeletal muscle cells in primary culture. Eur J Biochem 225:617–623
Boureau F, Luu M, Doubrere JF (1992) Comparative study of the validity of four French McGill Pain Questionnaire (MPQ) versions. Pain 50:59–65
Crozier RA, Ajit SK, Kaftan EJ, Pausch MH (2007) MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J Neurosci 27:4492–4496
Deldicque L, Decombaz J, Zbinden FH, Vuichoud J, Poortmans JR, Francaux M (2008) Kinetics of creatine ingested as a food ingredient. Eur J Appl Physiol 102:133–143
Derave W, Ozdemir MS, Harris RC, Pottier A, Reyngoudt H, Koppo K, Wise JA, Achten E (2007) Beta-alanine supplementation augment muscle carnosine content and attenuates fatigue during repeated isokinetic contraction bouts in trained sprinters. J Appl Physiol 103:1736–1743
Derave W, Everaert I, Beeckman S, Baguet A (2010) Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training. Sports Med 40:247–263
Fillion L, Gagnon P (1999) French adaptation of the shortened version of the Profile of Mood States. Psychol Rep 84:188–190
Harris RC, Jones G, Wise JA. The plasma concentration-time profile of b-alanine using a controlled-release formulation (Carnosyn™). FASEB J. 2008; 22:709.1[abstr.]
Harris RC, Tallon MJ, Dunnett M, Boobis L, Coakley J, Kim HJ, Fallowfield JL, Hill CA, Sale C, Wise JA (2006) The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids 30:279–289
Hill CA, Harris RC, Kim HJ, Harris BD, Sale C, Boobis LH, Kim CK, Wise JA (2007) Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids 32:225–233
Hoffman J, Ratamess NA, Ross R, Kang J, Magrelli J, Neese K, Faigenbaum AD, Wise JA (2008) Beta-alanine and the hormonal response to exercise. Int J Sports Med 29:952–958
Kamanna VS, Ganji SH, Kashyap ML (2009) The mechanism and mitigation of niacin-induced flushing. Int J Clin Pract 63:1369–1377
Kendrick IP, Harris RC, Kim HJ, Kim CK, Dang VH, Lam TQ, Bui TT, Smith M, Wise JA (2008) The effects of 10 weeks of resistance training combined with beta-alanine supplementation on whole body strength, force production, muscular endurance and body composition. Amino Acids 34:547–554
Kendrick IP, Kim HJ, Harris RC, Kim CK, Dang VH, Lam TQ, Bui TT, Wise JA (2009) The effect of 4 weeks beta-alanine supplementation and isokinetic training on carnosine concentrations in type I and II human skeletal muscle fibres. Eur J Appl Physiol 106:131–138
Noble BJ, Borg GA, Jacobs I, Ceci R, Kaiser P (1983) A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate. Med Sci Sports Exerc 15:523–528
Sale C, Saunders B, Harris RC (2010) Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance. Amino Acids 39:321–333
Sale C, Saunders B, Hudson S, Wise JA, Harris RC, Sunderland CD (2011) Effect of beta-alanine plus sodium bicarbonate on high-intensity cycling capacity. Med Sci Sports Exerc 43:1972–1978
Shacham S (1983) A shortened version of the Profile of Mood States. J Pers Assess 47:305–306
Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. (1983) Manual for the State-Trait Anxiety Inventory STAI (Form Y): self-evaluation questionnaire. Consulting Psychologists Press, Inc, Palo Alto
Stellingwerff T, Anwander H, Egger A, Buehler T, Kreis R, Decombaz J, Boesch C (2011) Effect of two beta-alanine dosing protocols on muscle carnosine synthesis and washout. Amino Acids. doi:10.1007/s00726-011-1054-4
Stout JR, Cramer JT, Zoeller RF, Torok D, Costa P, Hoffman JR, Harris RC, O’Kroy J (2007) Effects of beta-alanine supplementation on the onset of neuromuscular fatigue and ventilatory threshold in women. Amino Acids 32:381–386
Sweeney KM, Wright GA, Glenn BA, Doberstein ST (2010) The effect of beta-alanine supplementation on power performance during repeated sprint activity. J Strength Cond Res 24:79–87
Tan IK, Gajra B (2006) Plasma and urine amino acid profiles in a healthy adult population of Singapore. Ann Acad Med Singapore 35:468–475
Tiedje KE, Stevens K, Barnes S, Weaver DF (2010) Beta-alanine as a small molecule neurotransmitter. Neurochem Int 57:177–188
Van Kuilenburg AB, Stroomer AE, van LH, Abeling NG, Van Gennip AH (2004) New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid? Biochem J 379:119–124
Van Thienen R, Van Proeyen K, Vanden Eynde B, Puype J, Lefere T, Hespel P (2009) Beta-alanine improves sprint performance in endurance cycling. Med Sci Sports Exerc 41:898–903
Villemure C, Bushnell MC (2002) Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain 95:195–199
Zoeller RF, Stout JR, O’kroy JA, Torok DJ, Mielke M (2007) Effects of 28 days of beta-alanine and creatine monohydrate supplementation on aerobic power, ventilatory and lactate thresholds, and time to exhaustion. Amino Acids 33:505–510
Acknowledgments
This study was supported by Nestec Ltd., Vevey, Switzerland. Our thanks go to Eric Zaltas, Manuel Domingez Estevez and Marc Enslen for advice and support and to Sylviane Oguey-Araymon and Anny Blondel-Lubrano for technical assistance. The authors are employees of Nestec Ltd, which provides professional assistance, research, and consulting services for food, dietary, dietetic, and pharmaceutical products of interest to Nestlé Ltd. No other conflicts of interest are reported.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00726-013-1557-2.
Rights and permissions
About this article
Cite this article
Décombaz, J., Beaumont, M., Vuichoud, J. et al. Effect of slow-release β-alanine tablets on absorption kinetics and paresthesia. Amino Acids 43, 67–76 (2012). https://doi.org/10.1007/s00726-011-1169-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-011-1169-7